Evaluation of the Sanitary Safety of a Healthcare Professional Conference Held 9-11 June 2021 in Paris

NCT04918160 | Completed

• 1 other identifier: 2021-A01185-36
• Study Type: observational
• Target: 711
• Locations: 1 country
• Sites: 1

Brief Summary

The COVID-SRLF study will evaluate the sanitary safety of the French Intensive Care Society (FICS) annual meeting held in Paris Congress Center from June 9th to June 11th 2021 in the Coronavirus Disease 2019 (COVID-2019) pandemic situation. The primary objective is to determine the proportion of attendees with a positive antigenic COVID-19 screening test at day 7 (+/- 1) of their participation to the meeting. This rate will be compared to a cohort of health care professionals (medical doctors and paramedical professionals) from the same hospital ward as the attendees but who did not attend the meeting (stratified on centers, gender, age (\< and \>= 40 years, vaccination status (0, 1 or 2 doses) and socio-professional status (medical doctor, nurse, nurse assistant).

Conditions

Covid19

Outcome Measures

Primary Outcomes (1)

• Conference attendees COVID-19 prevalence at D7

  Proportion of conference attendees with a positive COVID-19 autotest at day 7 of the last day of the meeting (June 18th, 2021).

  Day 7 of the last day of the meeting (June 18th, 2021)

Secondary Outcomes (5)

• Controls COVID-19 prevalence at D7

  Day 7 of the last day of the meeting (June 18th, 2021)

• Proportion of conference attendees with COVID-19 symptoms at D21

  Day 21 of the last day of the congress (July 2, 2021)

• Proportion of conference attendees with COVID-19-related medical consultation at D21

  Day 21 of the last day of the congress (July 2, 2021)

• Proportion of conference attendees with COVID-19-related emergency department visit at D21

  Day 21 of the last day of the congress (July 2, 2021)

• Proportion of conference attendees with COVID-19-related hospitalisation at D21

  Day 21 of the last day of the congress (July 2, 2021)

Study Arms (2)

Conference Attendees

Volunteering healthcare practitioners (medical doctor, nurse, nurse assistant, physiotherapist and psychotherapist) attending the FICS annual congress will be proposed to participate to the study. After giving their consent, participants will be asked to perform a COVID-19 antigenic screening self-test at day 7 (+/- 1) of the last day of the meeting (June 11th 2021) and to fill a questionnaire at day 21 of the last day of the meeting (June 11th 2021).

Other: Exposure to the FICS annual meeting (June 9-11 2021, Paris Congress Center)

Controls

Volunteering healthcare practitioners (medical doctor, nurse, nurse assistant, physiotherapist and psychotherapist) not attending the FICS annual congress will be proposed to participate to the study. They will be recruited in the same medical departments as the Conference Attendees. After giving their consent, controls will be asked to perform a COVID-19 antigenic screening self-test at day 7 (+/- 1) of the last day of the meeting (June 11th 2021) and to fill a questionnaire at day 21 of the last day of the meeting (June 11th 2021).

Other: Exposure to the FICS annual meeting (June 9-11 2021, Paris Congress Center)

Interventions

Exposure to the FICS annual meeting (June 9-11 2021, Paris Congress Center) OTHER

The study will compare COVID-19 screening nasal antigenic self-test (Boiron Auto Test Covid Nasal) positivity at D7 and COVID-19 symptoms in the 21 days between participants to the FICS annual meeting held in June 9-11 2021 in the Paris Congress Center (conference attendees / exposed) and healthcare professionals who did not attend the meeting (controls / not exposed).

Conference Attendees; Controls

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Two cohorts of healthy volunteers will be followed during 21 days after the French Intensive Care Society annual meeting. A first cohort, Conference Attendees cohort, constituted of volunteering healthcare practitioners (medical doctor, nurse, nurse assistant, physiotherapist and psychotherapist) attending the FICS annual congress. The second cohort, Control cohort, will gather volunteering healthcare practitioners (medical doctor, nurse, nurse assistant, physiotherapist and psychotherapist) who dit not attend the FICS annual congress, recruited in the same medical departments as the Conference Attendees participants.

You may qualify if:

• Healthcare professional healthy volunteer
• Participation to at least one day of the FICS annual meeting (June 9-11 2021)

You may not qualify if:

• Non-healthcare professional (exhibitors, congress center employees)
• Refusal to participate to the study
• Person under legal protection
• Absence of social security affiliation

Sponsors & Collaborators

• French Society for Intensive Care: lead

Study Sites (1)

Centre des Congres

Paris, 75017, France

Location

Related Publications (1)

• SRLF Trial Group. Sanitary safety of the 2021 French Intensive Care Society medical conference: a case/control study. Ann Intensive Care. 2022 Feb 11;12(1):11. doi: 10.1186/s13613-022-00986-x.

  PMID: 35147794 DERIVED

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Eric Maury, MD, PhD

  French Society for Intensive Care

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 2, 2021
• First Posted: June 8, 2021
• Study Start: June 8, 2021
• Primary Completion: July 2, 2021
• Study Completion: July 2, 2021
• Last Updated: October 21, 2021

Record last verified: 2021-10

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)